The Cancer Immunotherapy Market was Worth $ 62 Billion in 2016 and Estimated to Reach $ 111.23 Billion by the end of 2021 With a Growing Potential of 12.40%.

Wednesday, November 30, 2016 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

HYDERABAD, India, November 30, 2016 /PRNewswire/ --

According to the report "Global Cancer Immunotherapy Market",

published by Market Data Forecast, the global market is projected to reach USD 111.23 billion by 2021, at a CAGR of 12.40% from 2016 to 2021.


) View report Description and Table of contents @

Healing of disease by improving and inducing immune response for the prevention is termed as immunotherapy. It is a type of biological therapy that is a type of treatment which uses substances made from living organisms to treat cancer. Cancer immunotherapy is an activation immunotherapy. It helps in inhibiting the growth of the cancer cells, stopping the cancer cells from spreading across the body, helping the immune system to fight better against the cancer cells. Download the free sample report @

The key drivers influencing the growth of Cancer immunotherapy market are increasing occurrence of cancer, changing life style, smoking and excessive alcoholic intake, high efficacy of immunotherapy compared to other treatments, less side effects associated with cancer immunotherapy, reduced chance of recurrence of cancer. Further, cancers like Melanoma shows resistance towards chemotherapy and radiation therapies. Enquiry before Buying @

However, the high cost of cancer therapies and the limited information on cancer immunobiology are the some of the major factors restraining the growth of the market.

The Cancer Immunotherapy Market is segmented as following:

Based on Application: 

  • Breast
  • Lung
  • Melanoma
  • Colorectal
  • Head & Neck
  • Prostate
  • others

Based on Product Type: 

  • Monoclonal Antibodies
  • Checkpoint inhibitors/immune modulators
  • Therapeutic cancer vaccines
  • Oncolytic virus immunotherapy
  • Cytokines
  • Adoptive T cell transfer
  • Adjuvant Immunotherapy
  • Interferons
  • Interleukins
  • BCG
  • Others

Based on Mode of Administration: 

  • Intravenous
  • Oral
  • Topical
  • Intravesical    

Based on End users: 

  • Hospitals
  • Clinics

Geographical Segmentation: 

  • North America Cancer Immunotherapy Market
  • Europe Cancer Immunotherapy Market
  • Asia-Pacific Cancer Immunotherapy Market
  • Latin America Cancer Immunotherapy Market
  • Middle East and Africa Cancer Immunotherapy Market

Some of the major companies influencing the dynamics of cancer immunotherapy market are F. Hoffmann-La Roche Ltd, Amgen, Viralytics, Novartis Pharmaceuticals Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals Limited, AstraZeneca plc, Medivation, Advaxis, Bristol-Myers Squibb, Merck & Co. and Celgene Corp, Immunomedics. Enquiry for Discount @

The Cancer Immunotherapy market study offers the following deliverables: 

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter's five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Checkout other related studies in the Therapeutics Segment: 

Cancer Monoclonal Antibodies Market:

Immunotherapy Drugs system Market:

Cancer Vaccines Market:

Ovarian Cancer Therapeutics Market:

Lung Cancer Therapeutics Market:

About Us: 

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Contact: Abhishek Shukla Team Lead (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail:

Visit MarketDataForecast Blog @

View latest Press Releases of MDF @

SOURCE Market Data Forecast

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store